Drug class
Protease Activator
Mechanism of action
Protease Activators [MoA]
General use cases
- Glioma
- adult and pediatric patients 1 year of age and older with diffuse midline glioma harboring an H3 K27M mutation with progressive disease following prior therapy
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
